Raloxifene-4'-D-glucuronide lithium salt

CAS: 182507-22-8

Ref. 3D-MR09926

Produktinformation

• Name: Raloxifene-4'-D-glucuronide lithium salt
• Synonyme: (4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-D4]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronic acid), 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-d4]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronicacid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid, Raloxifene-D4-4'-Glucuronide, β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl

Beschreibung

Raloxifene-4'-D-glucuronide lithium salt is a metabolite of raloxifene, an estrogen receptor modulator. It has been used in the treatment of osteoporosis and breast cancer. Raloxifene-4'-D-glucuronide lithium salt inhibits protein synthesis by inhibiting the activity of ribosomes. Raloxifene-4'-D-glucuronide lithium salt binds to microsomal preparations, which are organelles found in liver cells that synthesize proteins. This binding slows down the rate at which proteins are synthesized, leading to its anti-cancer properties.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 655.64 g/mol
• Formel: C₃₄H₃₄NO₁₀S·Li
• Reinheit: Min. 95%